Acura Pharmaceuticals announces conversion of debt

Palatine-based Acura Pharmaceuticals Inc. said Abuse Deterrent Pharma LLC has converted $6.9 million, or the entire principle and accrued interest of its loan to the company, into shares of Acura’s common stock.

Related posts